After a previous analysis revealing inaccurate marketing claims and other problems with online sales, the latest Yale study examines whether the rapid expansion of virtual prescribing has sacrificed basic clinical oversight, safeguards that can ensure people are getting the right doses, prevent side effects or keep those with eating disorders from obtaining the drugs
Tirzepatide, a dual GIP/GLP-1 receptor agonist, is a new incretin-based therapy for type 2 diabetes
This combination isnt just about achieving a number on the scale but about creating lasting changes in body composition that support lifelong health and wellness
Significant prior efforts across the pharmaceutical industry have failed to identify potent and efficacious small-molecule agonists of the GLP-1R ( 15, 16 )
Bloomberg Chiropractic Center & Fortify IV | Newton, IL 618-783-2424 or 618-783-3839 drbloomberg.com or fortifyiv.com Let me know if youd like a PDF handout version, or help turning this into a social media series or email sequence!